Balyasny Asset Management LLC Ab Cellera Biologics Inc. Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $64,744 - $112,176	-23,716 Reduced 40.53%	34,794 $102,000
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $187,288 - $260,632	43,657 Added 293.93%	58,510 $265,000
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $58,075 - $88,078	14,853 New	14,853 $84,000
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $6.42 Million - $8.61 Million	1,134,269 New	1,134,269 $7.33 Million
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $968,789 - $1.48 Million	102,193 Added 201.04%	153,025 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $467,654 - $695,381	50,832 New	50,832 $503,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $356,579 - $663,910	-62,339 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $465,048 - $881,473	62,339 New	62,339 $608,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.